Mizuho initiates coverage on Celldex stock with Outperform rating
PositiveFinancial Markets

Mizuho has started coverage on Celldex stock with an Outperform rating, indicating strong confidence in the company's future performance. This is significant as it may attract more investors and boost the stock's value, reflecting Mizuho's belief in Celldex's potential for growth in the biotech sector.
— Curated by the World Pulse Now AI Editorial System